Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trastuzumab + Chemotherapy for HER2+ Metastatic Colorectal Cancer
NCT00006015Phase 2Terminated
- Sponsor
- National Cancer Institute
- Start
- May 2000
- Primary completion
- Dec 2002
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of trastuzumab in colorectal cancer (CRC), sponsored by National Cancer Institute. Started May 2000; status: terminated.
02
Drugs
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT00006015.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00006015.